Get started
Author

Laura Mazzeo

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
2023 · A. Prelaj, V. Miskovic, et al. · Annals of Oncology · 388
PDF
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy
2021 · Giovanni Fucà, Teresa Beninato, et al. · Targeted Oncology · 62
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
2023 · Arsela Prelaj, Edoardo Gregorio Galli, et al. · Frontiers in Oncology · 48
PDF
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
2023 · Claudia Proto, Sara Manglaviti, et al. · Journal of Thoracic Oncology · 36
PDF
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
2024 · Valeria Sebri, Chiara Marzorati, et al. · Cancer Medicine · 26
PDF
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
2023 · Giuseppe Lo Russo, Arsela Prelaj, et al. · Journal for ImmunoTherapy of Cancer · 21
PDF
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
2023 · Arsela Prelaj, Monica Ganzinelli, et al. · Clinical Lung Cancer · 21
Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review
2024 · S. Berenice Urtecho, Leonardo Provenzano, et al. · Lung Cancer · 14
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
2022 · Emma Zattarin, Federico Nichetti, et al. · Frontiers in Oncology · 14
PDF
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
2023 · Arsela Prelaj, Monica Ganzinelli, et al. · Clinical Lung Cancer · 13
PDF
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
2021 · F. Platini, S. Cavalieri, et al. · Endocrine · 13
Sex differences in burden of adverse events in patients receiving immunotherapy.
2023 · Rosalba Miceli, Hanna Eriksson, et al. · Journal of Clinical Oncology · 11
PDF
Unleashing precision: A review of targeted approaches in pleural mesothelioma
2024 · Mario Occhipinti, Marta Brambilla, et al. · Critical Reviews in Oncology/Hematology · 10
Histologic Transformation of ALK-Rearranged Lung Adenocarcinomas to High-Grade LCNEC: Clinical and Molecular Description of Three Cases
2024 · Paolo Ambrosini, Daniela Miliziano, et al. · Clinical Lung Cancer · 9
PDF
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
2023 · Sara Manglaviti, Marta Bini, et al. · Lung Cancer · 7
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis
2020 · Riccardo Lobefaro, Emma Zattarin, et al. · Therapeutic Advances in Medical Oncology · 7
PDF
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study
2024 · Rosalba Miceli, Hanna Eriksson, et al. · Acta Oncologica · 6
PDF
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy
2022 · Emma Zattarin, Sara Manglaviti, et al. · Future Oncology · 5
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
2026 · Arsela Prelaj, Vanja Miskovic, et al. · Nature Medicine · 4
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs
2024 · Rita Leporati, Daniela Miliziano, et al. · Tumori Journal · 4
Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models
2026 · Federica Corso, Vittoria Peppoloni, et al. · Communications Medicine · 3
PDF
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non–Small-Cell Lung Cancer With Novel Driver Alterations
2023 · Marta Brambilla, Teresa Beninato, et al. · Clinical Lung Cancer · 3
PDF
Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models
2026 · Federica Corso, Aleksandra Zec, et al. · Cell Reports Medicine · 2
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer
2026 · Arsela Prelaj, Leonardo Provenzano, et al. · npj Precision Oncology · 2
PDF
Aiding data retrieval in clinical trials with large language models: The APOLLO 11 Consortium in advanced lung cancer patients.
2025 · Federica Corso, Laura Mazzeo, et al. · Journal of Clinical Oncology · 2
Works count: 96
Citation count: 739
H-index: 11
I10-index: 13
Year
Topic
Type